| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2019/02/15 | 06 : 00 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2019/02/12 | 23 : 47 | Edgar (US Regulatory) | Schedule 13g | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/06/08 | 05 : 35 | Edgar (US Regulatory) | Amended Tender Offer Statement by Issuer (sc To-i/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/11 | 05 : 20 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 36 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/09 | 05 : 11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/07 | 22 : 11 | Edgar (US Regulatory) | Tender Offer Statement by Issuer (sc To-i) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/07 | 21 : 30 | PR Newswire (US) | ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/07 | 21 : 28 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/07 | 19 : 00 | PR Newswire (US) | Amneal and Impax Complete Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/05 | 06 : 05 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/05/03 | 07 : 19 | PR Newswire (US) | Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600 | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/04/30 | 19 : 20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/04/28 | 07 : 50 | PR Newswire (US) | Amneal And Impax Receive FTC Clearance For Business Combination | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/04/28 | 07 : 30 | PR Newswire (US) | ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/04/14 | 06 : 04 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/04/11 | 02 : 59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/04/06 | 20 : 33 | PR Newswire (US) | Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 2018/04/06 | 06 : 24 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |